Bremelanotide (PT-141) / Tadalafil Troche
Compounded bremelanotide (PT-141) / tadalafil troches are prescription-only sublingual formulations used to support sexual arousal, desire, and erectile function. This combination therapy pairs bremelanotide—a melanocortin receptor agonist that enhances central sexual responsiveness—with tadalafil, a PDE5 inhibitor known for improving blood flow and sustaining erections. The sublingual troche form allows for rapid absorption and convenient, non-invasive administration. Commonly used in men’s sexual wellness and performance protocols, this compounded therapy is customized in strength and flavor based on provider-directed treatment plans.
Compounded bremelanotide (PT-141) / tadalafil troches are prescription-only sublingual formulations used to support sexual arousal, desire, and erectile function. This combination therapy pairs bremelanotide—a melanocortin receptor agonist that enhances central sexual responsiveness—with tadalafil, a PDE5 inhibitor known for improving blood flow and sustaining erections. The sublingual troche form allows for rapid absorption and convenient, non-invasive administration. Commonly used in men’s sexual wellness and performance protocols, this compounded therapy is customized in strength and flavor based on provider-directed treatment plans.
Compounded bremelanotide (PT-141) / tadalafil troches are prescription-only sublingual formulations used to support sexual arousal, desire, and erectile function. This combination therapy pairs bremelanotide—a melanocortin receptor agonist that enhances central sexual responsiveness—with tadalafil, a PDE5 inhibitor known for improving blood flow and sustaining erections. The sublingual troche form allows for rapid absorption and convenient, non-invasive administration. Commonly used in men’s sexual wellness and performance protocols, this compounded therapy is customized in strength and flavor based on provider-directed treatment plans.
